Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Differential Absorption Kinetics of Grape Seed Extract Polyphenols: A Pilot Study

NCT07886385 is registered in ClinicalTrials.gov with Clinical Nutrition Research Center, Illinois Institute of Technology as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07886385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Differential Absorption Kinetics of Grape Seed Extract Polyphenols: A Pilot Study
Lead sponsor
Clinical Nutrition Research Center, Illinois Institute of Technology
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 20, 2026
Completion date
October 1, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy adults

Arms

As registered; 2 arms.

  • Study 1 - MN-BP and Commercially Available GSE ExperimentalCommercially Available Grape Seed Extract, MN-BP Grape Seed Extract

    Participants in Study 1 will receive MN-BP and another commercially available grape seed extract (GSE) during separate intervention periods in a randomized, double-blinded, crossover design. GSEs will be administered in capsule form.

  • Study 2 - Gen 2 GSE Preparations ExperimentalGen 2 GSE - Mixture, Gen 2 GSE - Monomer-Enriched, Gen 2 GSE - Oligomer-Enriched, Gen 2 GSE - Polymer-Enriched

    Participants in Study 2 will receive next-generation (Gen 2) grape seed extract (GSE) preparations enriched in monomers, oligomers, polymers, or a mixture during separate intervention periods in a randomized, double-blinded, crossover design

Primary endpoints

Registered primary outcome measures; 2 primary.

  • Plasma concentrations of GSE-derived (poly)phenols and their metabolites Baseline through 24 hours after GSE consumption

    Plasma concentrations of parent GSE-derived (poly)phenolic compounds and their metabolites will be measured using ultra-high-performance liquid chromatography-mass spectrometry (UHPLC-MS) at different time points following each GSE intervention.

  • Urinary concentrations of GSE-derived (poly)phenols and their metabolites Baseline through 24 hours after GSE consumption

    Urine samples will be analyzed using ultra-high-performance liquid chromatography-mass spectrometry (UHPLC-MS) to quantify GSE-derived (poly)phenolic compounds and their metabolites following each GSE intervention

Lead sponsor's other trials

Clinical Nutrition Research Center, Illinois Institute of Technology, most recent start first.